Studies: Continuous glucose monitoring is safe in ICU setting

09/27/2013 | Medscape (free registration)

Studies presented at a diabetes conference found using subcutaneous continuous blood glucose monitoring for ICU patients who need insulin was as safe as point-of-care measurement and less expensive. Researchers from the Netherlands studied 178 patients, most on mechanical ventilation, and found no significant difference between the methods in the incidence of severe hypoglycemia but noted the cost of CGM was $87 per patient per day, compared with $120 for POCM.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA